PHARMA SWITCH
Annual accounts 2025
micro format, filed on 28-05-2026, 64 days before the deadlineTurnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €46,000. Estimated: probably between €17,000 and €98,000.
Balance sheet
balance sheet total €9,444 on 31-12-2025in euro
in euro
Position in the sector
17.4%
Higher than 36% of 22,924 companies in 2025.
0.99
Higher than 31% of 22,052 companies in 2025.
14.4%
Higher than 77% of 22,202 companies in 2025.
Net result: middle half · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: middle half
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Balance sheet: assets | ||||||||
20/58 |
9,444 | 7,363 | 11,632 | 19,686 | 25,989 | 28,984 | 20,435 | |
21/28 |
1,722 | 924 | 6,471 | 12,018 | 17,565 | 23,112 | 12,112 | |
22/27 |
1,722 | 924 | 6,471 | 12,018 | 17,565 | 23,112 | 12,112 | |
23 |
1,722 | - | - | - | - | - | - | |
24 |
- | 924 | 6,471 | 12,018 | 17,565 | 23,112 | 12,112 | |
29/58 |
7,722 | 6,438 | 5,161 | 7,668 | 8,424 | 5,872 | 8,323 | |
40/41 |
485 | 5,027 | 693 | 1,658 | 832 | 3,619 | 58 | |
40 |
185 | 5,027 | 693 | 1,338 | 185 | 3,149 | 58 | |
41 |
300 | - | - | 321 | 647 | 470 | - | |
54/58 |
6,953 | 176 | 3,280 | 4,936 | 6,504 | 1,122 | 7,158 | |
490/1 |
285 | 1,235 | 1,187 | 1,073 | 1,088 | 1,132 | 1,107 | |
| Balance sheet: equity and liabilities | ||||||||
10/49 |
9,444 | 7,363 | 11,632 | 19,686 | 25,989 | 28,984 | 20,435 | |
10/15 |
1,644 | 288 | 1,991 | 3,489 | 2,474 | 1,503 | 3,290 | |
10/11 |
6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | 6,200 | |
100 |
- | - | - | - | - | - | 18,600 | |
101 |
- | - | - | - | - | - | 12,400 | |
14 |
-4,556 | -5,912 | -4,209 | -2,711 | -3,726 | -4,697 | -2,910 | |
17/49 |
7,801 | 7,075 | 9,641 | 16,197 | 23,516 | 27,481 | 17,145 | |
17 |
- | - | - | 618 | 7,982 | 15,266 | 4,610 | |
170/4 |
- | - | - | 618 | 7,982 | 15,266 | 4,610 | |
42/48 |
7,801 | 6,775 | 9,641 | 15,580 | 15,333 | 12,215 | 12,535 | |
42 |
- | - | 618 | 7,365 | 7,283 | 7,202 | 6,067 | |
44 |
1,114 | 883 | 1,029 | 30 | 1,121 | 1,387 | 938 | |
440/4 |
1,114 | 883 | 1,029 | 30 | 1,121 | 1,387 | 938 | |
45 |
4,170 | 5,407 | 2,392 | 6,420 | 6,894 | 3,344 | 3,777 | |
450/3 |
4,170 | 3,707 | 2,392 | 6,420 | 4,894 | 3,344 | 2,027 | |
454/9 |
- | 1,700 | - | - | 2,000 | - | 1,750 | |
47/48 |
2,517 | 484 | 5,603 | 1,765 | 35 | 283 | 1,754 | |
492/3 |
- | 300 | - | - | 200 | - | - | |
| Income statement | ||||||||
9900 |
4,402 | 5,371 | 5,660 | 9,096 | 8,994 | 6,517 | 4,971 | |
630 |
1,052 | 5,547 | 5,547 | 5,547 | 5,547 | 4,622 | 5,505 | |
640/8 |
463 | 387 | 447 | 615 | 348 | 456 | 1,839 | |
66A |
- | - | - | - | - | 2,193 | - | |
9901 |
2,887 | -564 | -334 | 2,934 | 3,100 | -754 | -2,373 | |
75/76B |
0 | - | 0 | - | - | 6 | 0 | |
75 |
0 | - | 0 | - | - | 6 | 0 | |
65/66B |
125 | 125 | 146 | 290 | 307 | 506 | 419 | |
65 |
125 | 125 | 146 | 290 | 307 | 506 | 419 | |
9903 |
2,762 | -689 | -480 | 2,644 | 2,793 | -1,254 | -2,792 | |
67/77 |
1,406 | 1,014 | 1,018 | 1,629 | 1,823 | 532 | 118 | |
9904 |
1,356 | -1,703 | -1,498 | 1,015 | 970 | -1,786 | -2,910 | |
9905 |
1,356 | -1,703 | -1,498 | 1,015 | 970 | -1,786 | -2,910 | |
| Appropriation of the result | ||||||||
9906 |
-4,556 | -5,912 | -4,209 | -2,711 | -3,726 | -4,697 | -2,910 | |
14P |
-5,912 | -4,209 | -2,711 | -3,726 | -4,697 | - | - | |
| Document | ||||||||
The notes to these accounts have 5 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the filed accounts (PDF).
Source: Annual accounts 2025 (PDF), filed on 28-05-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 28-05-2026 | 2026-00123972 | |
| 31-12-2024 | micro format | 29-05-2025 | 2025-00110476 | |
| 31-12-2023 | micro format | 31-05-2024 | 2024-00104348 | |
| 31-12-2022 | micro format | 05-06-2023 | 2023-00106203 | |
| 31-12-2021 | micro format | 31-05-2022 | 2022-20042304 | |
| 31-12-2020 | micro format | 18-06-2021 | 2021-22300325 | |
| 31-12-2019 | micro format | 19-06-2020 | 2020-19700101 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| 3,939 | 4,983 | 5,213 | 8,481 | 8,646 | 3,869 | 3,132 | ||
| 2,408 | 3,844 | 4,049 | 6,562 | 6,517 | 2,836 | 2,595 | ||
| 1,850 | 0 | 0 | 0 | 0 | 27,735 | 17,617 | ||
| 6,777 | -3,104 | -1,656 | -1,568 | 5,382 | -6,036 | - | ||
| -79 | -337 | -4,481 | -7,912 | -6,909 | -6,343 | -4,212 | ||
| 17.4% | 3.9% | 17.1% | 17.7% | 9.5% | 5.2% | 16.1% | ||
| 0.99 | 0.95 | 0.54 | 0.49 | 0.55 | 0.48 | 0.66 | ||
| 4.75 | - | 4.84 | 4.64 | 9.51 | 18.28 | 5.21 | ||
| 82.5% | - | -75.3% | 29.1% | 39.2% | -118.8% | -88.5% | ||
| 14.4% | -23.1% | -12.9% | 5.2% | 3.7% | -6.2% | -14.2% | ||
| 31.62 | 39.88 | 35.72 | 29.23 | 28.21 | - | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €1,850 | - | - | - | - |
| €1,052 | €5,547 | €5,547 | €5,547 | €5,547 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on PHARMA SWITCH
The operating result for 2025 is a profit of €2,887, after a loss of €564 in 2024. It is the highest result since 2022.
Debt's share of the balance-sheet total falls from 96.1% to 82.6%. Equity and debt are higher.